Published in Mol Pharmacol on December 01, 2000
Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis (2008) 1.27
L-arginine metabolism and its impact on host immunity against Leishmania infection. Immunol Res (2008) 1.21
Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol (2001) 0.99
Arginase and arginine dysregulation in asthma. J Allergy (Cairo) (2011) 0.92
STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells. PLoS One (2012) 0.81
Modulation of the oscillatory mechanics of lung tissue and the oxidative stress response induced by arginase inhibition in a chronic allergic inflammation model. BMC Pulm Med (2013) 0.77
Induction of arginase II by intestinal epithelium promotes the uptake of L-arginine from the lumen of Cryptosporidium parvum-infected porcine ileum. J Pediatr Gastroenterol Nutr (2008) 0.76
Inhibition of nitric oxide synthase abrogates lipopolysaccharides-induced up-regulation of L-arginine uptake in rat alveolar macrophages. Br J Pharmacol (2001) 0.76
Retracted Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery. Mol Pharm (2013) 0.76
Expression Profile of Cationic Amino Acid Transporters in Rats with Endotoxin-Induced Uveitis. Mediators Inflamm (2016) 0.75
Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev (1989) 2.66
A Streptomyces rimosus aphVIII gene coding for a new type phosphotransferase provides stable antibiotic resistance to Chlamydomonas reinhardtii. Gene (2001) 2.50
[A 32-year-old patient with diarrhoea and acute kidney failure]. Internist (Berl) (2006) 2.02
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology (2000) 2.02
Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther (1998) 1.99
Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.70
The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol (1999) 1.68
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Rhizobium japonicum nitrogenase Fe protein gene (nifH). J Bacteriol (1984) 1.60
Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer (2000) 1.56
Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut (1987) 1.54
Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.47
Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology (2000) 1.43
Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.43
[Chronic pancreatitis]. Dtsch Med Wochenschr (2008) 1.41
Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol (2002) 1.40
[Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder]. Z Gastroenterol (2005) 1.40
Gene expression and morphological changes in surgically injured carotids of spontaneously hypertensive rats. J Vasc Res (2002) 1.40
Relationship between bispectral index, electroencephalographic state entropy and effect-site EC50 for propofol at different clinical endpoints. Br J Anaesth (2005) 1.39
Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia (2002) 1.38
Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.38
Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.37
Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol (1996) 1.37
Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst (1999) 1.36
The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res (2000) 1.36
In Rhizobium japonicum the nitrogenase genes nifH and nifDK are separated. J Bacteriol (1983) 1.35
High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33
Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology (2000) 1.30
SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.28
ATP, alpha,beta-methylene ATP and suramin as tools for characterization of vascular P2x receptors in the pithed rat. J Auton Pharmacol (1989) 1.28
Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med (2000) 1.27
Biotin synthase from Escherichia coli, an investigation of the low molecular weight and protein components required for activity in vitro. J Biol Chem (1995) 1.25
Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.22
Inhibitory effects of verapamil, prenylamine and D 600 on Ca2+-dependent noradrenaline release from the sympathetic nerves of isolated rabbit hearts. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.22
Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam Clin Pharmacol (1994) 1.20
Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med (2001) 1.18
Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mutat (1998) 1.17
Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm Gen Sect (1993) 1.16
GABAB receptor-mediated inhibition of serotonin release in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.16
Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D,L-indospicine, effects on L-arginine utilization by nitric oxide synthase. Br J Pharmacol (1997) 1.15
Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. Eur J Surg Oncol (2007) 1.14
Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol (2000) 1.09
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.09
Spectroscopic characterization of flavin mononucleotide bound to the LOV1 domain of Phot1 from Chlamydomonas reinhardtii. Photochem Photobiol (2002) 1.09
Esophageal intramural pseudodiverticulosis: endoscopic diagnosis and therapy. Dis Esophagus (2013) 1.07
Inhibition of arginase by NG-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett (1995) 1.06
Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells. Diabetes (1985) 1.04
Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.03
The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.03
A CDE/CHR tandem element regulates cell cycle-dependent repression of cyclin B2 transcription. FEBS Lett (2000) 1.03
Mutual interaction of histamine H3-receptors and alpha 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol (1992) 1.03
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer (2002) 1.03
[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol (2012) 1.02
Endothelin-1 in rat periaqueductal gray area induces hypertension via glutamatergic receptors. Hypertension (1995) 1.01
Primary amyloidosis of the mesentery and the retroperitoneum presenting with lymphedema. Am J Gastroenterol (1998) 1.01
Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Neuropharmacology (2001) 1.01
A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma. Ann Oncol (2000) 1.00
Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages. Br J Pharmacol (2001) 0.99
Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.99
Acetylcholine in isolated airways of rat, guinea pig, and human: species differences in role of airway mucosa. Am J Physiol (1996) 0.99
Cationic proteins inhibit L-arginine uptake in rat alveolar macrophages and tracheal epithelial cells. Implications for nitric oxide synthesis. Am J Respir Cell Mol Biol (1999) 0.99
Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.99
Epithelium-derived inhibition of [3H]acetylcholine release from the isolated guinea-pig trachea. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.98
High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia (2001) 0.98
Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J Exp Med (1993) 0.98
p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A. Oncogene (2006) 0.98
Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull (1998) 0.98
Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.98
Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.97
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors. Br J Cancer (2011) 0.96
Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.96
MioC is an FMN-binding protein that is essential for Escherichia coli biotin synthase activity in vitro. J Biol Chem (2000) 0.96
Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.96
Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol (2000) 0.95
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J (2008) 0.95
[Faecal pyruvate kinase type M2--a valid screening parameter for colorectal cancer? Preliminary results from a multicenter comparative study]. Dtsch Med Wochenschr (2004) 0.94
Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: involvement of 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.94
Alternative mechanisms for tiotropium. Pulm Pharmacol Ther (2009) 0.94
Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.94
Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.94
Role of pancreatic enzymes and their substrates in autodigestion of the pancreas. In vitro studies with isolated rat pancreatic acini. Gastroenterology (1989) 0.94
Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.94
Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.94
Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.94
Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.93
Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.93
Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol (1983) 0.93
Involvement of presynaptic H3 receptors in the inhibitory effect of histamine on serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.92
Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem Int (2002) 0.92
Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur J Pharmacol (1990) 0.92
Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.92
Cytokines and VEGF induction in orthodontic movement in animal models. J Biomed Biotechnol (2012) 0.91
Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.91
Purification, characterization, DNA sequence and cloning of a pimeloyl-CoA synthetase from Pseudomonas mendocina 35. Biochem J (1999) 0.91
Effects of dopamine infusion on plasma catecholamines in preterm and term newborn infants. Eur J Pediatr (1991) 0.91
Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients. Cancer (1992) 0.91
Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.91